CONMED (CNMD) Earnings Date, Estimates & Call Transcripts → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free CNMD Stock Alerts $68.36 +0.38 (+0.56%) (As of 05/1/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateJul. 24EstimatedActual EPS (Apr. 24) $0.79 Beat By $0.05 Consensus EPS (Apr. 24) $0.74 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get CONMED Earnings AlertsEnter your email address below to receive the latest news and earnings results for CNMD and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCNMD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CNMD Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here CONMED Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.89$0.89$0.89 Q2 20241$1.07$1.07$1.07 Q3 20241$1.10$1.10$1.10 Q4 20241$1.28$1.28$1.28 FY 20244$4.34$4.34$4.34 Q1 20251$1.26$1.26$1.26 Q2 20251$1.28$1.28$1.28 Q3 20251$1.46$1.46$1.46 CNMD Earnings Date and InformationCONMED last released its quarterly earnings results on April 24th, 2024. The reported $0.79 earnings per share for the quarter, topping analysts' consensus estimates of $0.74 by $0.05. The firm earned $312.27 million during the quarter, compared to analyst estimates of $307.06 million. CONMED has generated $2.61 earnings per share over the last year ($2.61 diluted earnings per share) and currently has a price-to-earnings ratio of 26.2. Earnings for CONMED are expected to grow by 28.14% in the coming year, from $4.30 to $5.51 per share. CONMED has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 24th, 2024 based off prior year's report dates.Read More CONMED Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 7/24/2024Estimated)------- 4/24/2024Q1 2024$0.74$0.79+$0.05$0.95$307.06 million$312.27 million 1/31/2024Q4 2023$1.11$1.06($0.05)$1.07$332.94 million$327.05 million10/25/2023Q3 2023$0.83$0.90+$0.07$1.30$301.22 million$304.58 million 7/26/2023Q2 2023$0.79$0.83+$0.04$1.23$306.15 million$317.70 million 4/26/2023Q1 2023$0.60$0.66+$0.06$1.26$266.66 million$295.47 million 2/2/2023Q4 2022$0.93$0.42($0.51)($0.02)$302.48 million$250.87 million Get the Latest News and Ratings for CNMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter. 10/26/2022Q3 2022$0.75$0.77+$0.02$0.06$282.23 million$275.09 million7/27/2022Q2 2022$0.76$0.76-$7.17$273.78 million$277.19 million5/4/2022Q1 2022$0.62$0.70+$0.08$0.93$235.55 million$242.33 million1/26/2022Q4 2021$1.05$1.07+$0.02$1.39$277.45 million$273.97 million10/27/2021Q3 2021$0.77$0.80+$0.03$1.13$255.22 million$248.83 million7/28/2021Q2 2021$0.62$0.71+$0.09$1.01$247.87 million$255.16 million CONMED Earnings - Frequently Asked Questions When is CONMED's earnings date? CONMED has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 24th, 2024 based off last year's report dates. Learn more on CNMD's earnings history. Did CONMED beat their earnings estimates last quarter? In the previous quarter, CONMED (NYSE:CNMD) reported $0.79 earnings per share (EPS) to beat the analysts' consensus estimate of $0.74 by $0.05. Learn more on analysts' earnings estimate vs. CNMD's actual earnings. How can I listen to CONMED's earnings conference call? The conference call for CONMED's latest earnings report can be listened to online. Listen to Conference Call How can I read CONMED's conference call transcript? The conference call transcript for CONMED's latest earnings report can be read online. Read Transcript How can I view CONMED's earnings report? CONMED's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does CONMED generate each year? CONMED (NYSE:CNMD) has a recorded annual revenue of $1.24 billion. How much profit does CONMED generate each year? CONMED (NYSE:CNMD) has a recorded net income of $64.46 million. CNMD has generated $2.61 earnings per share over the last four quarters. What is CONMED's price-to-earnings ratio? CONMED (NYSE:CNMD) has a trailing price-to-earnings ratio of 26.19 and a forward price-to-earnings ratio of 15.90. The price/earnings-to-growth ratio is 0.64. What is CONMED's EPS forecast for next year? CONMED's earnings are expected to grow from $4.30 per share to $5.51 per share in the next year, which is a 28.14% increase. More Earnings Resources from MarketBeat Related Companies: InMode Earnings Results TransMedics Group Earnings Results LivaNova Earnings Results Soleno Therapeutics Earnings Results BioLife Solutions Earnings Results Integer Earnings Results Masimo Earnings Results agilon health Earnings Results Dyne Therapeutics Earnings Results TG Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: PayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting Season This page (NYSE:CNMD) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyAI “wealth window” is closing June 25thParadigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CONMED Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.